O2 Concepts expands into Europe
By HME News Staff
Updated 9:57 AM CDT, Thu July 17, 2025
MIDDLEBURY, Conn. - O2 Concepts has received medical device regulation (MDR) certification for its Oxlife Liberty POC and Oxlife Independence POC with DNA Technology. The certification gives the company the ability to market and distribute the devices across the European Union member countries. “For us, MDR approval is more than expanding into new markets — it is a reflection of our company’s high standards for our POCs in clinical efficacy and reliable performance,” said Elby Beal, CEO of O2 Concepts. “We are in the innovation business, designing and building advanced portable oxygen devices that perform better and over a longer term for our customers and patients." To support its European expansion, O2 Concepts is partnering with leading distributors to bring Oxlife devices to high-demand EU markets. With MDR approval in Europe and recent MDSAP approval for Health Canada, the company says it is well-positioned to meet growing global demand for its portable oxygen solutions.
Comments